FARSA

Phenylalanine--tRNA ligase alpha subunit · Q9Y285 · FARSA on Sugi Atlas →

0 patent compounds predicted against FARSA, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to FARSA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes PHASE3RECRUITING
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. PHASE1/PHASE2COMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders nanCOMPLETED
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Study of a Candidate Gene Involved in Goldenhar Syndrome. nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Gene Analysis of Parkinson's Disease nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Genetic Analysis of Fraser Syndrome and Fryns Syndrome nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study nanCOMPLETED
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) nanRECRUITING
Parkinson's Diseases Susceptibility Genes and Pesticides nanCOMPLETED
Genetic Analysis of Parkinson's Disease nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Natural History Study of FDXR Mutation-related Mitochondriopathy nanCOMPLETED
Parkinson's Families Project nanRECRUITING
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam nanUNKNOWN
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Natural History and Genetic Studies of Usher Syndrome nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a FARSA binder may also engage these)

ProteinNameSimilarity
Q5RFA2 1.000 Q5RFA2 →
Q8C0C7 1.000 Q8C0C7 →
Q7SYV0 1.000 Q7SYV0 →
Q505J8 1.000 Q505J8 →
Q1JPX3 0.998 Q1JPX3 →
Q6AZG6 0.998 Q6AZG6 →
Q5ZJQ2 0.996 Q5ZJQ2 →
Q0W0X9 0.995 Q0W0X9 →
Q9T034 0.994 Q9T034 →
Q9W3J5 0.993 Q9W3J5 →
P15625 0.993 P15625 →
A2ST81 0.991 A2ST81 →
O42870 0.991 O42870 →
O84843 0.991 O84843 →
Q5PBV2 0.991 Q5PBV2 →
A3CT76 0.990 A3CT76 →
A9ILQ3 0.990 A9ILQ3 →
Q1IJG7 0.989 Q1IJG7 →
Q0I8C9 0.989 Q0I8C9 →
B2S4L0 0.989 B2S4L0 →
Q2FQD6 0.989 Q2FQD6 →
O83938 0.989 O83938 →
Q9RUV5 0.989 Q9RUV5 →
B8ELG9 0.989 B8ELG9 →
Q9PL83 0.989 Q9PL83 →
B2RLI5 0.989 B2RLI5 →
Q8TUA2 0.989 Q8TUA2 →
Q5PAH7 0.988 Q5PAH7 →
Q4JW06 0.988 Q4JW06 →
Q6G5E3 0.988 Q6G5E3 →